Cogstate Limited (ASX: CGS)

Market Cap	186.96M
Revenue (ttm)	65.09M
Net Income (ttm)	8.17M
Shares Out	172.31M
EPS (ttm)	0.05
PE Ratio	22.98
Forward PE	25.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,030
Open	1.050
Previous Close	1.075
Day's Range	1.050 - 1.095
52-Week Range	0.795 - 1.500
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About Cogstate

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2024, Cogstate's revenue was $43.43 million, an increase of 7.36% compared to the previous year's $40.45 million. Earnings were $5.45 million, an increase of 52.75%.

Financial numbers in USD